 Mersana Therapeutics, Inc. NASDAQ:MRSN Q1 2022 Earnings Conference Call May 9, 2022 8:00 AM ET Company Participants Jason Fredette - Senior Vice President, Investor Relations and Corporate Communications Anna Protopapas - President, CEO Director Arvin Yang - Senior VP Chief Medical Officer Tim Lowinger - Chief Science Technology Officer Brian DeSchuytner - Senior VP CFO Conference Call Participants Jonathan Chang - SVB Leerink Boris Peaker - Cowen Daniel Wolle - JPMorgan Colleen Kusy - Baird David Nierengarten - Wedbush Securities Operator Good morning, and welcome to Mersana Therapeutics First Quarter 2022 Conference Call and webcast. Currently all participants are in a listen-only mode. 